Detalles de la búsqueda
1.
Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD.
J Am Soc Nephrol
; 32(7): 1779-1790, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33883252
2.
Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study.
Nephrol Dial Transplant
; 36(9): 1731-1741, 2021 08 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33650630
3.
Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.
Diabetes Obes Metab
; 20(2): 453-457, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28786530
4.
Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.
Diabetes Obes Metab
; 20(1): 77-84, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28608617
5.
Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial.
Diabetes Obes Metab
; 19(6): 874-882, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28177187
6.
Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open-label study in Japan.
Ther Apher Dial
; 25(5): 642-653, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33283981
Resultados
1 -
6
de 6
1
Próxima >
>>